Loading...
11th Annual Orthobiologic Symposium

TOBI Virtual 2020

Maximum Credits: 12 AMA PRA Category 1creditstm

How to Claim Credit

To claim educational credits you must follow these instructions:

Please go to: fcmcme.org/tobi
Select the Claim Credit Button.
If already a fcmcme.org user, login.

  1. If NOT previously registered with FCMCME.org, select new user and complete the user information form and Submit.

Enter Course Code: TOB61220z and submit.
Complete the online post exam and evaluation, following the prompts.

Once completed a green Print/View Certificate button will be displayed within your “User Record” You may return to your FCMCME.org anytime in the future to access your CE user records or to review courses.

AMA PRA Category 1 Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Foundation for Care Management (FCM) and The Orthobiologic Institute (TOBI). The Foundation for Care Management is accredited by the ACCME to provide continuing medical education for physicians.

FCM designates this educational activity for a maximum of 12 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in this activity.

The ACCME defines a “Commercial Interest” as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

12 CME for Symposium ARE available FOR LIVE, On-Demand, or FLASH DRIVE

Upon completion of this activity, the healthcare professional will be able to:

Faculty Speakers and Disclosures

  1. 1. Adam Anz, MD, has a Royalties relationship with Arthrex; Research Support relationship with Owens
    Recovery Science; Research Support relationship with Edward Via College of Osteopathic.
    2. Joanne Borg-Stein, MD, has no relevant relationships with commercial interests to disclose.
    3. Jay Bowen, DO, has no relevant relationships with commercial interests to disclose.
    4. Scott Bruder, MD, has no relevant relationships with commercial interests to disclose.
    5. Don Buford, MD, is a Speaker/Speaker’s Bureau relationship with Orthotalk, Inc; Board Member, relationship with Interventional Orthobiologic Foundation.
    6. Sherman Canapp, DMV, MS, CCRT, DACVS, DACVSMR, has a Consultant relationship with Everost/Steris; Consultant relationship with Companion Animal Health; Consultant relationship with RTI
    Surgical; Owner/Founder relationship.
    7. Christopher Centeno, MD, has no relevant relationships with commercial interests to disclose.
    8. Brian Cole, MD, has Consultant relationship with Arthrex; Consultant relationship with Flexion; Consultant relationship with Regentis; Consultant relationship with Smith & Nephew; Consultant.
    9. Ramon Cugat, MD, PhD, has a Consultant relationship with Smith & Nephew; research collaboration
    relationship with BTI.
    10. Kevin Darr, MD, has a Consultant relationship with Lipogems.
    11. Tim Davis, MD, Consultant relationship with Abbott; Owner/Founder relationship with Alpha Diagnostics; Owner/Founder relationship with Atai Health Sciences; Consultant relationship.
    12. Diego Delgado, PhD, has no relevant relationships with commercial interests to disclose.
    13. Francesco Della Villa, MD, has no relevant relationships with commercial interests to disclose.
    14. Rahul Desai, MD, has no relevant relationships with commercial interests to disclose.
    15. Jason Dragoo, MD, Consultant relationship with Zimmer; Consultant relationship with DePuy/Mitek; Consultant relationship with Linvatec; Consultant relationship with Ossur; Consultant relationship with Smith & Nephew; Consultant relationship with Moximed; Consultant relationship with Harvest Technologies; Consultant relationship with Flexion Therapeutics; Consultant relationship with Breg; Consultant relationship with Arthrex; Research Funding relationship with MTF; Consultant relationship with DonJoy; Consultant relationship with RTI Surgical; Consultant relationship with Bioventus; Consultant relationship with KCRN Research; Consultant relationship with Sideline Sports Doc, LLC; Consultant relationship with Sideline Sports Doc, LLC; Consultant relationship with JRF Ortho; Consultant relationship with EPIC CRISPR
    16. Ryan Dregalla, PhD, Owner/Founder relationship with R&D Regenerative Laboratory Resources, LLC; Owner/Founder relationship with Dregalla Medical Technologies, LLC; Owner/Founder relationship with Lucina Biosciences, LLC
    17. Jack Farr, MD, is a Consultant relationship with Organogenesis.
    18. John Ferrell, MD, has no relevant relationships with commercial interests to disclose.
    19. Taco Gosens, MD, is a grant recipient relationship with Zimmer Biomet.
    20. Jeffrey Gusenoff, MD, has no relevant relationships with commercial interests to disclose.
    21. Josh Hackel, MD, has no relevant relationships with commercial interests to disclose.
    22. Joanne Halbrecht, MD, Consultant relationship with Consultant, Lipogems®
    23. Kim Harmon, MD, has no relevant relationships with commercial interests to disclose.
    24. David Karli, MD, has no relevant relationships with commercial interests to disclose.
    25. Michael Khadavi, MD, is a Consultant relationship with Arthrex.
    26. Dallas Kinsbury, MD, has no relevant relationships with commercial interests to disclose.
    27. Fernando Kirchner, MD, has no relevant relationships with commercial interests to disclose.
    28. Gregory Lutz, MD, has no relevant relationships with commercial interests to disclose.
    29. Nicola Maffulli, MD, PhD, has no relevant relationships with commercial interests to disclose.
    30. Jeremy Magalon, MD, has a Consultant relationship with Macopharma; Consultant relationship with Horiba; Consultant relationship with Fidia.
    31. Gerard Malanga, MD, Editor relationship with Editor, textbook: Musculoskeletal Physical Examination: An E; Editor relationship with Editor, textbook: Atlas of Ultrasound-Guided Musculoskeletal; Consultant
    relationship with Consultant: Lipogems; Consultant relationship with Consultant: Lipogems; Advisory Committee Member relationship with Medical Advisory Board/stockholder: Biorestorative Technolog; Advisory Committee Member relationship with Medical Advisory Board/stockholder: TendoNova; Advisory Committee Member relationship with Founder/Principal: DataBiologics database registry
    32. Laxmaiah Manchikanti, MD, has no relevant relationships with commercial interests to disclose.
    33. Bert Mandelbaum, MD, Consultant relationship with Arthrex; Consultant relationship with The Win
    Within.
    34. Robert Marx, DDS, has no relevant relationships with commercial interests to disclose.
    35. Tais Mazzini-Setti, MD, has no relevant relationships with commercial interests to disclose.
    36. Kenneth Mautner, MD, Royalties relationship with McGraw Hill; Consultant relationship with Tenez;
    Other relationship with Elsevier.
    37. Randy Miller, MD, has not relevant relationships with commercial interests to disclose.
    38. Allan Mishra, MD, has a Royalties relationship with Zimmer Biomet; Royalties relationship with Depuy/Johnson and Johnson.
    39. Sean Mulvaney, MD, has no relevant relationships with commercial interests to disclose.
    40. Anu Navani, MD, has no relevant relationships with commercial interests to disclose.
    41. Kristin Oliver, MD, Consultant relationship with Arthrex Inc; Royalties relationship with Arthrex.
    42. Andre Panagos, MD, has no relevant relationships with commercial interests to disclose.
    43. Raj Pandya, MD, has a Consultant relationship with Lipogems.
    44. Alberto Panero, DO, is a Consultant relationship with Arthrex Inc; Speaker/Speaker’s Bureau
    relationship with Ossur; Speaker/Speaker’s Bureau relationship with Tenex.
    45. Luga Podest, MD, has a Speaker/Speakers Bureau relationship with Arthrex Inc. Naples, FL.
    46. Christopher Rogers, MD, has a Shareholder / Consultant relationship with Personalized Stem Cells, Inc.
    47. Steven E. Sampson, DO, has no relevant relationships with commercial interests to disclose.
    48. Mikel Sanchez, MD, has no relevant relationships with commercial interests to disclose.
    49. William Seeds, MD, has no relevant relationships with commercial interests to disclose.
    50. Mitchell Sheinkop, MD, has no relevant relationships with commercial interests to disclose.
    51. Bernard Siege, JD, has no relevant relationships with commercial interests to disclose.
    52. Brian Shiple, DO, has no relevant relationships with commercial interests to disclose.
    53. Annemarie Tilton, MD, has a Shareholder relationship with Samumed, LLC.
    54. Paul Tortland, DO, has no relevant relationships with commercial interests to disclose.
    55. Thomas C. Vangsness, MD, Management Role, Travel Sponsorship relationship with Keralink; Private
    Equity relationship with CarthroniX Inc; Private Equity relationship with Align-Med Inc; Private Equity relationship with Parcus Medical LLC; Private Equity relationship with Replenish Inc.
    56. Victor Vaquerizo, MD, has no relevant relationships with commercial interests to disclose.
    57. Hunter Vincent, DO, has no relevant relationships with commercial interests to disclose.
    58. Christopher Williams, MD, has no relevant relationships with commercial interests to disclose.

Planning Committee:
  • Steven E. Sampson, DO, has no relevant relationships with commercial interests to disclose.
  • Danielle Aufiero, MD, has no relevant relationships with commercial interests to disclose.
  • Randy B. Miller, MD, is a Speaker for Tulip Medical, CAREstream, and Emctye, and Advisor to Harvest Technologies and Terumo BCT.

Disclosure Declaration

It is the policy of Foundation for Care Management (FCM) to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any financial relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by FCM prior to accreditation of the activity. FCM planners and reviewers, outside of those listed, have no financial relationships to disclose.

 
Method of Participation/Criteria for Success

To receive continuing education credit, participants should review all program materials in their entirety, complete and submit the online evaluation. A statement of credit will be available for printing upon successful completion. If you have questions about this CME/CE activity, please contact FCM at debbylong@fcmcme.org

 
Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

WELCOME TO TOBI VIRTUAL